Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE

CVS to Pay $20M to Settle SEC Case

By Pharmaceutical Processing | August 5, 2013

WOONSOCKET, R.I. (AP) — CVS Caremark Corp. plans to pay $20 million to resolve a Securities and Exchange Commission investigation into some public disclosures and securities deals involving emloyees, among other items.

The Woonsocket, R.I., drugstore operator said Friday it will not have to restate its earnings, and it has already set aside money for the civil penalty.

It said the agreement resolves an SEC investigation that started in 2011 and focused on some things that happened in the final two quarters of 2009.

The company said in 2011 that the SEC had asked for corporate records on several issues, including public disclosures in 2009 related to pharmacy benefits management and its Medicare prescription-drug benefit businesses.

The SEC also requested information about transactions in company securities by current and former employees and some aspects of an accounting adjustment tied to its purchase of Longs Drug Stores in 2008.

CVS Caremark said it neither admits nor denies anything in agreeing to the settlement, which resolves alleged violations of the Securities Act of 1933 and the Securities Exchange Act of 1934, including anti-fraud provisions.

The settlement still must receive SEC and federal court approval.

CVS Caremark runs the nation’s second-largest drugstore chain, with more than 7,500 stores, and it also is one of the nation’s biggest pharmacy benefits managers. PBMs runs drug plans for employers, insurers and other customers.

The company will report on its second-quarter results Tuesday.

CVS Caremark shares fell 34 cents to $61.83 in midday trading while the Standard & Poor’s 500 index also dropped slightly.

Related Articles Read More >

This is a photo of the Fujifilm Diosynth Biotechnologies plant under construction in Holly Springs, North Carolina.
Fujifilm, Regeneron ink $3B U.S. manufacturing agreement
This is the logo of Johnson & Johnson.
J&J breaks ground on $2B manufacturing facility in North Carolina
sherwin-williams-pharma-facility (1)
Sherwin-Williams expands flooring solutions for pharma facilities
PHARMAP 2025: Pharma leaders converge in Berlin for fifth anniversary summit
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE